WV negligence lawsuit gets another day in the courtroom
By
Elizabeth Newman
Aug 01, 2012
A verdict against a nursing home of slightly over $90 million is being reconsidered in West Virginia due to a verdict-form error.
CMS names 10 drugs slated for Medicare price negotiation
By
John Roszkowski
Aug 30, 2023
The Biden administration announced Tuesday the first 10 prescription drugs that would be selected for negotiation under the Medicare Drug Price Negotiation Program designed to lower the costs of prescription...
Higher authority may hear religious suit
By
Elizabeth Newman
Oct 01, 2012
A former nursing home activities aide allegedly fired over refusing to pray the rosary with a Catholic resident can proceed with a religious discrimination claim, a federal court ruled in September.
Review of antibiotic usage needed in long-term care facilities, expert urges
By
Elizabeth Newman
May 03, 2013
Long-term care administrators and directors should have an antibiotic stewardship program that takes the entire facility into account, an infection control expert said Thursday.
Newly unveiled artificial leg uses mind control to function
By
John O'Connor
Nov 01, 2013
Nursing home residents with an amputated leg might soon gain new walking independence, thanks to a motorcycle accident victim and researchers at the Rehabilitation Institute of Chicago.
Sabra Health Care REIT is the latest in a string of real estate investment trusts looking to distance themselves from problematic skilled nursing portfolios.
ITUpdate for September 2014
Sep 01, 2014
» The Centers for Medicare & Medicaid Services launched a technical assistance program, called the Medicaid Innovation Accelerator Program, in July. The goal is to help with payment and delivery system...
CMS creating infection control course for Final Rule compliance
By
Kimberly Marselas
Mar 27, 2018
A new, multi-day course is being designed by the Centers for Medicare & Medicaid to help nursing homes prepare for an infection preventionist requirement included in the revised Final Rules of participation.
Most US adults with type 2 diabetes meet criteria for GLP-RAs, SGLT2is
Feb 28, 2023
More than 82% US adults with type 2 diabetes meet the criteria to be prescribed the drugs, yet only 9% use either of them.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.